Oxford Begins Human Trials for Ebola Vaccine

Clinical trials for a new ebola vaccine are set to begin by the Jenner Institute. A total of 26 patients will receive a dose of the vaccine, which was developed using viral vector technology, as seen with the AstraZeneca COVID-19 vaccine.